```html

Friction Rub (Pericardial)

What is Friction rub (pericardial)?

A pericardial friction rub is a distinctive, high‑pitched, scratchy sound heard with a stethoscope when the two layers of the pericardium (the thin membrane surrounding the heart) rub against each‑other during the cardiac cycle. The sound is typically heard **both during systole and diastole**, unlike most heart murmurs that occur only in one phase. It is a clinical sign—not a disease itself—indicating inflammation or irritation of the pericardial layers.

The pericardium consists of an inner visceral layer (epicardium) tightly adherent to the heart muscle and an outer parietal layer attached to the fibrous pericardium. When inflammation separates these layers, the normally “lubricated” surfaces become rough, producing the audible rub.

Common Causes

Pericardial friction rubs can arise from many conditions that cause pericardial inflammation (pericarditis) or other mechanical irritation. The most frequent causes include:

• Viral pericarditis – Coxsackie B, echovirus, adenovirus, influenza, COVID‑19.
• Bacterial infections – Staphylococcus, Streptococcus, Mycobacterium tuberculosis.
• Autoimmune diseases – Systemic lupus erythematosus, rheumatoid arthritis, scleroderma.
• Post‑myocardial infarction (Dressler syndrome) – Autoimmune pericarditis weeks after a heart attack.
• Uremic pericarditis – Accumulation of toxins in advanced kidney failure.
• Chest trauma – Blunt or penetrating injury to the thorax.
• Radiation therapy – Damage to pericardial tissue after treatment for lung or breast cancer.
• Neoplastic involvement – Direct invasion by lung, breast, or lymphoma cells.
• Post‑cardiac surgery – Inflammation after valve replacement, coronary artery bypass, or device implantation.
• Metabolic disorders – Hypothyroidism or hyperthyroidism can rarely provoke pericarditis.

In many patients, the exact trigger remains idiopathic; however, the rub still guides clinicians to investigate these possibilities.

Associated Symptoms

While a friction rub can be an isolated finding, it often accompanies other signs of pericardial irritation or systemic illness. Common associated symptoms include:

• Chest pain – Sharp, pleuritic, worsens with deep breathing or lying flat, improves when sitting up and leaning forward.
• Fever – Low‑grade fevers are frequent in infectious pericarditis.
• Dyspnea – Shortness of breath, especially when fluid accumulates (pericardial effusion).
• Palpitations – Irregular awareness of heartbeats caused by pericardial inflammation.
• Fatigue & malaise – General feeling of illness.
• Swelling of the legs or abdomen – May signal cardiac tamponade if a large effusion develops.
• Syncope or near‑syncope – Due to reduced cardiac output when tamponade occurs.

When to See a Doctor

Because a pericardial friction rub signals inflammation that can progress to serious complications (e.g., cardiac tamponade, constrictive pericarditis), timely medical evaluation is essential. Seek care promptly if you experience:

• New or worsening chest pain that is sharp and changes with position.
• Fever >100.4°F (38°C) accompanying chest discomfort.
• Shortness of breath at rest or with minimal activity.
• Sudden swelling of the neck veins, abdomen, or lower extremities.
• Feeling light‑headed, faint, or any loss of consciousness.
• Persistent cough or hoarseness accompanied by chest pain.

Diagnosis

Diagnosing a pericardial friction rub involves a combination of history taking, physical examination, and targeted investigations.

1. Physical examination

• Auscultation – Using a diaphragm and bell of the stethoscope at the left lower sternal border; the rub is best heard when the patient leans forward and holds breath at end‑expiration.
• It may have three components: one during systole, one during early diastole, and one during late diastole.

2. Electrocardiogram (ECG)

• Diffuse ST‑segment elevation and PR‑segment depression are classic for acute pericarditis.
• Absence of these changes does not rule out pericarditis; the rub can be the sole clue.

3. Imaging

• Echocardiography – First‑line to detect pericardial effusion, assess tamponade physiology, and evaluate ventricular function.
• Chest X‑ray – May show an enlarged cardiac silhouette if a sizable effusion is present.
• Cardiac MRI or CT – Provides detailed tissue characterization, helpful for suspected constrictive pericarditis or neoplastic involvement.

4. Laboratory tests

• Complete blood count (CBC) – Look for leukocytosis.
• Inflammatory markers (CRP, ESR) – Usually elevated.
• Cardiac enzymes (troponin) – May be mildly raised if myocardium is involved.
• Serologic testing – Viral panels (e.g., Coxsackie, COVID‑19) or autoimmune antibodies (ANA, RF) based on clinical suspicion.
• Renal function and urea nitrogen – To assess for uremic pericarditis.

5. Pericardial fluid analysis (rare)

If a large effusion requires drainage, fluid is sent for cytology, bacterial culture, PCR for viruses, and tuberculosis testing.

Treatment Options

Treatment is aimed at relieving inflammation, controlling pain, and preventing complications. The approach varies with the underlying cause.

1. Pharmacologic therapy

• Non‑steroidal anti‑inflammatory drugs (NSAIDs) – Ibuprofen 600‑800 mg every 6‑8 h or naproxen 500 mg twice daily for 1–2 weeks is first‑line for most acute pericarditis.
• Colchicine – 0.5 mg twice daily (adjust for weight and renal function) for 3 months reduces recurrence rates (per 2015 ESC guidelines).
• Corticosteroids – Prednisone 0.2‑0.5 mg/kg/day reserved for refractory cases, autoimmune pericarditis, or when NSAIDs/colchicine are contraindicated. Taper slowly to avoid relapse.
• Antibiotics/antivirals – Targeted therapy for bacterial or specific viral etiologies (e.g., azithromycin for atypical bacteria, antiviral agents for COVID‑19).
• Uremic management – Intensified dialysis or initiation of renal replacement therapy.

2. Procedural interventions

• Therapeutic pericardiocentesis – Removal of large or tamponade‑causing effusions.
• Pericardial window surgery – For recurrent effusions or constrictive physiology.
• Anti‑inflammatory intrapericardial injections – Occasionally used in refractory cases.

3. Home and supportive measures

• Rest and avoidance of strenuous activity for 1‑2 weeks.
• Elevate the head of the bed or sit up to reduce chest‑pain intensity.
• Apply a warm compress to the chest if it eases discomfort (avoid heat if infection is suspected).
• Stay well‑hydrated unless fluid restriction is advised for heart failure.

Prevention Tips

While not all cases are preventable, several strategies can lower the risk of developing pericardial inflammation:

• Maintain up‑to‑date vaccinations (influenza, COVID‑19, pneumococcal) to reduce viral or bacterial infections.
• Control chronic diseases: keep blood pressure, diabetes, and cholesterol within target ranges.
• Adhere to renal‑failure management plans, including regular dialysis schedules.
• Avoid excessive alcohol consumption and illicit drug use, which can precipitate myocarditis and secondary pericarditis.
• Promptly treat respiratory infections and seek care for persistent fevers.
• Use protective equipment (seat belts, airbags, helmets) to diminish the likelihood of chest trauma.
• If you have an autoimmune condition, follow your rheumatologist’s medication regimen and attend regular follow‑ups.

Emergency Warning Signs

Key Take‑aways

A pericardial friction rub is an audible clue that the heart’s protective sac is inflamed. While often benign and self‑limited, it can herald serious complications such as cardiac tamponade or constrictive pericarditis. Recognizing the rub, understanding its common causes, and seeking prompt medical evaluation are vital. Treatment usually involves anti‑inflammatory medication, with colchicine playing a central role in preventing recurrence. Lifestyle measures, vaccination, and control of chronic illnesses can help reduce risk.

For personalized advice, always consult a healthcare professional. The information above reflects current guidelines from reputable sources such as the Mayo Clinic, the CDC, the NIH, the World Health Organization, and the Cleveland Clinic.

```